Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
J., Vuppalanchi, R., Boursier, J., Bugianesi, E., Yoneda, M., Behling, C., Cummings, O
These investigations will provide new research directions and therapeutic targets for diagnosing, treating, and preventing skeletal metabolic diseases
It may also be used to administer medications or other medical therapy such as blood products or electrolytes to correct electrolyte imbalances
doi:10.1111/ijd.13585
Double anthracycline (mitoxantrone + idarubicin) therapy with cyclosporin a (CSA) to block multidrug resistance (MDR) as salvage therapy for relapsed or refractory acute myelogenous leukemia (R-AML)
US$ 20.18
US$ 27.66
US$ 28.21
US$ 22.41
US$ 26.47
US$ 21.92
US$ 28.79
US$ 21.18
